Geography once drove disparity, but access now hinges on how effectively centers can employ modern donor-utilization tools.

Jonathan Cunningham discusses how AI might help, from patient selection to event adjudication.

The study of LAAO cases provides physicians with evidence they can cite when requesting tools for additional protection.

Today, the American College of Cardiology (ACC) and American Heart Association (AHA), in partnership with multiple other societies, released new guidelines for the management of patients with ...

Both CV mortality and major bleeding were rarer when antiplatelets weren’t added, with no tradeoff in ischemic events.

The vast majority of patients presenting with type 1 NSTEMI undergo invasive coronary angiography in the US, with most receiving PCI, according to an analysis presented this week at CRT 2026. But as ...

At 3 years, Agent still outshined uncoated balloons. Registry data show rapid uptake of the DCB in the year after its FDA approval.

In hypothetical situations, physicians chose intensive treatment more often if BP and mobility metrics were available.

Operative mortality fell over time, but there was a concerning uptick in recent years attributed to low-volume sites.

The study emphasizes the importance of vigilance with diet and exercise, among other things, to reduce CV risk in type 2 diabetes.

There was a consensus that more data are needed to answer this question, with discussions about what such a trial would look like.

Outcomes and expenses were similar with transplant and elective LVAD, but urgent LVAD after ECMO fared much worse.